Puma Biotechnology Announces Phase III Trial of PB272 in Extended Adjuvant Breast Cancer (ExteNET Trial) Demonstrates Statistically Significant Improvement in Disease Free Survival

… of PB272 in Extended Adjuvant Breast Cancer (ExteNET Trial) Demonstrates Statistically Significant … 41 countries with early-stage HER2-positive breast cancer who had undergone surgery and … with HER2-positive breast cancer and patients with non-small cell lung cancer, breast cancer and …